Follow
Mary Wood
Mary Wood
Data Scientist, Phase Genomics
No verified email
Title
Cited by
Cited by
Year
Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2
A Nguyen, JK David, SK Maden, MA Wood, BR Weeder, A Nellore, ...
Journal of virology 94 (13), e00510-20, 2020
5992020
Androgen receptor activity in T cells limits checkpoint blockade efficacy
X Guan, F Polesso, C Wang, A Sehrawat, RM Hawkins, SE Murray, ...
Nature 606 (7915), 791-796, 2022
1852022
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone
JN Graff, TM Beer, JJ Alumkal, RE Slottke, WL Redmond, GV Thomas, ...
Journal for immunotherapy of cancer 8 (2), 2020
892020
Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
MA Wood, BR Weeder, JK David, A Nellore, RF Thompson
Genome medicine 12, 1-16, 2020
722020
Pembrolizumab (Pembro) plus enzalutamide (Enz) in metastatic castration resistant prostate cancer (mCRPC): Extended follow up.
JN Graff, JJ Alumkal, RF Thompson, A Moran, GV Thomas, MA Wood, ...
Journal of Clinical Oncology 36 (15_suppl), 5047-5047, 2018
422018
Population-level distribution and putative immunogenicity of cancer neoepitopes
MA Wood, M Paralkar, MP Paralkar, A Nguyen, AJ Struck, K Ellrott, ...
BMC cancer 18, 1-15, 2018
372018
neoepiscope improves neoepitope prediction with multivariant phasing
MA Wood, A Nguyen, AJ Struck, K Ellrott, A Nellore, RF Thompson
Bioinformatics 36 (3), 713-720, 2020
252020
Retained introns in long RNA-seq reads are not reliably detected in sample-matched short reads
JK David, SK Maden, MA Wood, RF Thompson, A Nellore
Genome biology 23 (1), 240, 2022
82022
Phase II study of pembrolizumab with enzalutamide (Enz) in metastatic, castration-resistant prostate cancer (mCRPC): 30 patient expansion with examination of tumour …
JN Graff, AE Moran, RE Slottke, GV Thomas, JJ Alumkal, RF Thompson, ...
Annals of Oncology 30, v329, 2019
52019
Genetic analysis of multiple primary melanomas arising within the boundaries of congenital nevi depigmentosa
AM Fuiten, RG Fankhauser, DJ Smit, MS Stark, TF Enright, MA Wood, ...
Pigment cell & melanoma research 34 (6), 1123-1130, 2021
42021
pepsickle rapidly and accurately predicts proteasomal cleavage sites for improved neoantigen identification
BR Weeder, MA Wood, E Li, A Nellore, RF Thompson
Bioinformatics 37 (21), 3723-3733, 2021
42021
Tumor Mutation Burden—From Doubts to Concerns
MA Wood, A Nellore, RF Thompson
JAMA oncology 5 (12), 1808-1809, 2019
42019
Urine DNA for monitoring chemoradiotherapy response in muscle‐invasive bladder cancer: a pilot study
NS Gordon, LA Baxter, A Goel, R Arnold, B Kaur, W Liu, SJ Pirrie, ...
BJU international 129 (1), 32-34, 2022
32022
The system can't perform the operation now. Try again later.
Articles 1–13